EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Baseline memory B-cell enrichment and heightened B-cell activation are associated with irAEs

Sarah Soussan, Amel Ait Ahcene, Rayan El Kholdi, Lucie Garnier, Lou Lelievre, Sofiene Tifoura, Magali Fradet, Lea Guyonnet, Coralie Guerin, Nicolas Tchitchek, Jean-Sébastien Hulot, Assié Eslami Abriz und 7 weitere

Cancer Immunology, Immunotherapy · 06.11.2026

DOI: 10.1007/s00262-026-04617-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 06.11.2026. Verfasst von Sarah Soussan und 18 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministère de l’enseignement supérieur et de la recherche, Ligue Contre le Cancer, Institut National Du Cancer.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) targeting CTLA-4 and PD-1 improve cancer outcomes but can disrupt peripheral tolerance, triggering immune-related adverse events (irAEs). While T-cell-mediated mechanisms have been extensively studied, the contribution of B cells remains incompletely understood. We performed phenotypic, functional, and signaling analyses of peripheral B cells in melanoma (PREDIMEL) and pan-cancer (AMICI) cohorts. PREDIMEL included 37 patients in PRED_1 (22 with irAEs; 23% of irAE cases grade ≥3) and 23 patients in PRED_2, enriched for severe toxicity (18 with irAEs; 15 with grade 3–4 events). AMICI included 45 patients (31 with irAEs; 35.5% of irAE cases grade ≥3). Before treatment, PRED_1 patients who subsequently developed irAEs showed enrichment of IgD⁻ memory and activated memory B cells and reduced CD32 (FcγRII) expression, whereas AMICI patients with irAEs displayed increased plasmablast frequencies and CD95 expression. These observations supported heightened B-cell activation across cohorts. Phospho-flow analyses in PRED_2 revealed enhanced BCR-induced Syk and PLCγ2 phosphorylation in memory B cells from patients who subsequently developed irAEs. Functional assays in PRED_1 also showed increased antibody secretion under in vitro stimulation conditions. Despite inter-cohort heterogeneity, these observational findings link a pre-existing activated B-cell state to subsequent irAE development and highlight B-cell activation and regulation as potential avenues for understanding susceptibility to ICI-associated toxicity.

Förderung

  • Ministère de l’enseignement supérieur et de la recherche
  • Ligue Contre le Cancer
  • Institut National Du Cancer

Zitieren

APA

Soussan, S., Ahcene, A. A., Kholdi, R. E., Garnier, L., Lelievre, L., Tifoura, S., Fradet, M., Guyonnet, L., Guerin, C., Tchitchek, N., Hulot, J., Abriz, A. E., Mirabel, M., Meda, L. D., Joubert, P., Cremer, I., Lebbé, C., Durey, M. D., & Sibéril, S. (2026). Baseline memory B-cell enrichment and heightened B-cell activation are associated with irAEs. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04617-3

Vancouver

Soussan S, Ahcene AA, Kholdi RE, Garnier L, Lelievre L, Tifoura S, et al. Baseline memory B-cell enrichment and heightened B-cell activation are associated with irAEs. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04617-3

BibTeX
@article{Soussan2026,
  author = {Soussan, Sarah and Ahcene, Amel Ait and Kholdi, Rayan El and Garnier, Lucie and Lelievre, Lou and Tifoura, Sofiene and Fradet, Magali and Guyonnet, Lea and Guerin, Coralie and Tchitchek, Nicolas and Hulot, Jean-Sébastien and Abriz, Assié Eslami and Mirabel, Mariana and Meda, Laetitia da and Joubert, Pierre-Emmanuel and Cremer, Isabelle and Lebbé, Céleste and Durey, Marie-Agnès Dragon and Sibéril, Sophie},
  title = {Baseline memory B-cell enrichment and heightened B-cell activation are associated with irAEs},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  doi = {10.1007/s00262-026-04617-3}
}
Kostenlos starten →